You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

anticancer agents

Showing 1 - 25 of 6,200
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Endometrial Cancer Trial (Pembrolizumab, GEN1046)

Not yet recruiting
  • Advanced Endometrial Cancer
  • (no location specified)
Sep 14, 2023

Drug-drug Interactions in Patients Treated With Anticancer

Recruiting
  • Prostatic Neoplasm
  • data collection
  • Besançon, France
    Centre Hospitalier Universitaire de Besançon
Nov 9, 2022

Cancer, Tumor, Solid, Malignant Tumor Trial (OR502, Cemiplimab)

Not yet recruiting
  • Cancer
  • +6 more
  • (no location specified)
Oct 16, 2023

Chemo-induced Nausea and Vomiting (CINV) Trial in Shanghai (Granisetron Transdermal Delivery System)

Recruiting
  • Chemotherapy-induced Nausea and Vomiting (CINV)
  • Granisetron Transdermal Delivery System
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 19, 2022

Breast Tumors Trial in Japan (E7090, Fulvestrant, Exemestane)

Recruiting
  • Breast Neoplasms
  • Nagoya, Aichi, Japan
  • +10 more
Nov 11, 2022

Lymphoma, Non-Hodgkin, Hodgkin Lymphoma Trial in Worldwide (AZD3470)

Not yet recruiting
  • Lymphoma
  • +2 more
  • Miami, Florida
  • +10 more
Nov 13, 2023

Metastatic Castration Resistant Prostate Cancer Trial in Atlanta, Minneapolis, Nashville (Rucaparib, Enzalutamide, Abiraterone)

Active, not recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • Atlanta, Georgia
  • +2 more
Jan 24, 2022

Advanced Solid Tumours That Are MTAP Deficient Trial in Spain, United States (AZD3470)

Not yet recruiting
  • Advanced Solid Tumours That Are MTAP Deficient
  • New Haven, Connecticut
  • +3 more
Nov 8, 2023

Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Multiple Chronic Conditions Trial in Ann Arbor (Patient Reported Outcome

Terminated
  • Chronic Myeloid Leukemia
  • +2 more
  • Patient Reported Outcome Measure (PROM)
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Nov 21, 2022

Hepatocellular Carcinoma, Biliary Tract Cancer Trial in Worldwide (MEDI5752, Bevacizumab, Lenvatinib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Biliary Tract Cancer
  • Birmingham, Alabama
  • +44 more
Mar 17, 2023

Tumors Trial in Dallas, San Antonio, Toronto (GSK4381562, Dostarlimab)

Recruiting
  • Neoplasms
  • Philadelphia, Pennsylvania
  • +4 more
Nov 18, 2022

Solid Tumor, Lymphoma Trial in Beijing (HG146, PD-(L)1 antibody)

Recruiting
  • Solid Tumor
  • Lymphoma
  • Beijing, China
    National Cancer Center/Cancer Hospital
Mar 16, 2022

Cancer, Adherence to Medication Regime, Symptom Management Trial in Ankara (Mobile Application Intervention)

Completed
  • Cancer
  • +2 more
  • Mobile Application Intervention
  • Ankara, Turkey
    Başkent University
Nov 6, 2020

Tumors Trial in Worldwide (GSK6097608, Dostarlimab, GSK4428859A (EOS884448))

Recruiting
  • Neoplasms
  • Los Angeles, California
  • +9 more
Aug 26, 2022

Breast Cancer, Colorectal Cancer, Ovarian Cancer Trial in United States (ATRC-101, Pembrolizumab, Pegylated liposomal

Recruiting
  • Breast Cancer
  • +15 more
  • ATRC-101
  • +2 more
  • Phoenix, Arizona
  • +10 more
Sep 28, 2022

Breast Cancer, Breast Cancer Stage IV, HER2-negative Breast Cancer Trial in United States (Mirdametinib, Fulvestrant)

Recruiting
  • Breast Cancer
  • +6 more
  • Middletown, New Jersey
  • +3 more
Dec 28, 2021

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Japan (Niraparib)

Active, not recruiting
Has Results
  • Ovarian Cancer
  • +2 more
  • Nagoya, Aichi, Japan
  • +26 more
Feb 7, 2022

Endometrial Cancer, Gastric Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Datopotamab deruxtecan

Not yet recruiting
  • Endometrial Cancer
  • +4 more
  • Datopotamab deruxtecan (Dato-DXd)
  • +8 more
  • Los Angeles, California
  • +52 more
Aug 3, 2022

Reporting of AdVerse Events Associated With AnTicAncerRapy

Recruiting
  • Cancer
  • Antineoplastic and Immunomodulating Agents
  • Caen, Basse Normandie, France
    Alexandre Joachim
Jan 4, 2021

Tumors Trial in Worldwide (GSK3174998, Pembrolizumab)

Completed
Has Results
  • Neoplasms
  • Boston, Massachusetts
  • +7 more
Apr 26, 2021

Tumors, Pancreatic Trial in United States (GSK3145095, Pembrolizumab)

Terminated
Has Results
  • Neoplasms, Pancreatic
  • Indianapolis, Indiana
  • +5 more
Jul 16, 2020

Solid Tumor, Breast Cancer, Colon Cancer Trial in Worldwide (LY3039478, Taladegib, Abemaciclib)

Completed
  • Solid Tumor
  • +4 more
  • Miami, Florida
  • +10 more
Aug 13, 2020

Oral Anticancer Medications inMultilingual and Multicultural

Unknown status
  • Adults
  • +2 more
  • Measure adherence behaviors
  • Brussels, Belgium
  • +1 more
Nov 2, 2020

Advanced and Metastatic Gastric or Gastroesophageal Adenocarcinoma Trial in Spain, United States (MLN1117, TAK-659, Alisertib)

Terminated
Has Results
  • Advanced and Metastatic Gastric or Gastroesophageal Adenocarcinoma
  • Lake Success, New York
  • +5 more
Aug 19, 2019

CIPN - Chemo-Induced Peripheral Neuropathy, Breast Cancer Trial in Copenhagen (Elasto-Gel™ mitts for hands: TM7008, and slippers

Recruiting
  • CIPN - Chemotherapy-Induced Peripheral Neuropathy
  • Breast Cancer
  • Elasto-Gel™ mitts for hands: TM7008, and slippers for feet: SL3000; Southwest Technologies, Inc., North Kansas City, MO, USA
  • Copenhagen, Denmark
    Maria E Lendorf
Jun 23, 2023